<"from 9 cents to 4 dollars"> ==> try $5 by 10am ?
<"He similarly expected partnering in the 2nd half of 2010. Do you think an announcement will come earlier?">
hi Biomund - well your question has been answered now !
<"How do you see this investment working out considering the long path ahead?">
It is actually still a cheap stock, and has two distinct programs. No doubt the Tovaxin one is the most difficult. I think though the CEO is totally honest, and these days they have to be - they are in partnership discussions. And it may take a long time, especially if it is Big Pharma - and a new concept, which this is.
Market Data 
Markets 
AI
